Literature DB >> 12901576

Vaccines against hantaviruses.

Brian Hjelle1.   

Abstract

Rodent-borne hantaviruses are etiologic agents for hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome in the Old World and New World, respectively. These often severe diseases are relatively uncommon in most parts of the world and are sufficiently genetically variable that widely cross-protective vaccines will probably need to be polyvalent. The current status of hantavirus vaccines shall be reviewed and both conventional and speculative new vaccine technologies that may evolve within the field shall be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12901576     DOI: 10.1586/14760584.1.3.373

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  14 in total

Review 1.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

Review 2.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

3.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

4.  Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice.

Authors:  Feng Liu; Mifang Liang; Shouchun Cao; Qinzhi Liu; Quanfu Zhang; Chuan Li; Shuo Zhang; Shiwen Wang; Dexin Li
Journal:  Virol J       Date:  2011-09-23       Impact factor: 4.099

5.  Induction of specific humoral and cellular immune responses in a mouse model following gene fusion of HSP70C and Hantaan virus Gn and S0.7 in an adenoviral vector.

Authors:  Linfeng Cheng; Lan Yu; Xingan Wu; Kai Li; Fang Wang; Liang Zhang; Wei Ye; Puyuan Li; Fanglin Zhang; Zhikai Xu
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.

Authors:  Bryce M Warner; Derek R Stein; Rohit K Jangra; Megan M Slough; Patrycja Sroga; Angela Sloan; Kathy L Frost; Stephanie Booth; Kartik Chandran; David Safronetz
Journal:  Viruses       Date:  2019-07-13       Impact factor: 5.048

7.  Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host.

Authors:  Jessica R Spengler; Elaine Haddock; Don Gardner; Brian Hjelle; Heinz Feldmann; Joseph Prescott
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

8.  Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection.

Authors:  Francisca Valdivieso; Pablo Vial; Marcela Ferres; Chunyan Ye; Diane Goade; Analia Cuiza; Brian Hjelle
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

Review 9.  Immunological mechanisms mediating hantavirus persistence in rodent reservoirs.

Authors:  Judith D Easterbrook; Sabra L Klein
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

10.  A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice.

Authors:  Lan Yu; Wentao Bai; Xingan Wu; Liang Zhang; Lei Zhang; Puyuan Li; Fang Wang; Ziyu Liu; Fanglin Zhang; Zhikai Xu
Journal:  Virol J       Date:  2013-10-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.